Skip to main content
. 2024 Dec 2;15:1493735. doi: 10.3389/fimmu.2024.1493735

Figure 4.

Figure 4

Prognostic and clinical value of the iMRS. (A–F) Overall survival and recurrence-free survival of patients relative to iMRS in cohort 1, cohort 2, and the surgical resection cohort. (G) iMRS of patients with complete CR/PR or PD/SD to anti-PD-1/PD-L1 therapy in the immunotherapy cohort. Mann–Whitney test, *p < 0.05. (H) Overall survival of patients relative to iMRS in immunotherapy cohort. CR, complete response; PR, partial response; PD, progressive disease; SD, stable disease.